Max Lerchenberger
Impact in
-
- Cell Adhesion Molecules Research
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
Papers in
-
- Cell Adhesion Molecules Research 2
-
- Amoebic Infections and Treatments 1
- Co-authors
- Christoph A. Reichel (6 shared papers)Markus Rehberg (6 shared papers)Péter Bihari (3 shared papers)Fritz Krombach (4 shared papers)Stefan Zahler (3 shared papers)Marc Praetner (3 shared papers)Martin Holzer (2 shared papers)Fritz Krombach (2 shared papers)
- Journals
- Toxicology (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Circulation (1 paper)Blood (1 paper)Biomaterials (1 paper)
- Partner nations
- GermanySlovakiaSwitzerland
In The Last Decade
Max Lerchenberger
7 papers receiving 436 citations
Peers
Comparison fields: 5 of 75
- Immunology and Allergy 31
- Immunology 86
- Hematology 36
- Biomaterials 46
- Critical Care and Intensive Care Medicine 13
Countries citing papers authored by Max Lerchenberger
This map shows the geographic impact of Max Lerchenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Lerchenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Lerchenberger more than expected).
Fields of papers citing papers by Max Lerchenberger
This network shows the impact of papers produced by Max Lerchenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Lerchenberger. The network helps show where Max Lerchenberger may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Lerchenberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 126 | |
| 2 | 2009 | 110 | |
| 3 | 2011 | 61 | |
| 4 | 2010 | 43 | |
| 5 | 2013 | 37 | |
| 6 | 2011 | 34 | |
| 7 | 2019 | 33 |
About Max Lerchenberger
Max Lerchenberger is a scholar working on Immunology and Allergy, Infectious Diseases, Critical Care and Intensive Care Medicine, Epidemiology and Biomaterials, having authored 7 papers that have together received 444 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (2 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (1 paper), Amoebic Infections and Treatments (1 paper), Protease and Inhibitor Mechanisms (1 paper), Quantum Dots Synthesis And Properties (1 paper), ZnO doping and properties (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Immunology and Allergy (31 citations), Immunology (86 citations), Hematology (36 citations), Biomaterials (46 citations) and Critical Care and Intensive Care Medicine (13 citations). Max Lerchenberger has collaborated with scholars based in Germany, Slovakia and Switzerland. Frequent co-authors include Christoph A. Reichel, Markus Rehberg, Péter Bihari, Fritz Krombach, Stefan Zahler, Marc Praetner, Martin Holzer, Fritz Krombach, Bernd Uhl and Alexander G. Khandoga. Their work appears in journals such as Toxicology, Arteriosclerosis Thrombosis and Vascular Biology, Circulation, Blood and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.